PGGM Investments’s West Pharmaceutical WST Stock Holding History

PGGM Investments’s Portfolio WST Stock Details WST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-4,921	Closed	-$1.1M	–	341
2025 Q1	$1.1M	Sell	4,921 -7,336	-60%	-$2.02M	0.01%	300
2024 Q4	$4.01M	Sell	12,257 -1,117	-8%	-$352K	0.05%	212
2024 Q3	$4.01M	Hold	13,374	–	–	0.05%	212
2024 Q2	$4.41M	Hold	13,374	–	–	0.06%	193
2024 Q1	$5.29M	Hold	13,374	–	–	0.08%	181
2023 Q4	$4.71M	Hold	13,374	–	–	0.07%	195
2023 Q3	$5.02M	Hold	13,374	–	–	0.09%	188
2023 Q2	$5.12M	Sell	13,374 -305	-2%	-$109K	0.08%	198
2023 Q1	$4.74M	Sell	13,679 -888	-6%	-$259K	0.08%	208
2022 Q4	$3.43M	Sell	14,567 -1,384	-9%	-$328K	0.06%	234
2022 Q3	$3.92M	Buy	+15,951	New	+$4.86M	0.07%	231
2022 Q1	$12.4M	Hold	26,370	–	–	0.06%	244
2021 Q4	$12.4M	Buy	26,370 +2,020	+8%	+$869K	0.06%	244
2021 Q3	$10.3M	Buy	24,350 +13,317	+121%	+$5.61M	0.05%	268
2021 Q2	$3.96M	Buy	11,033 +177	+2%	+$58.5K	0.02%	312
2021 Q1	$3.06M	Buy	10,856 +10,177	+1,499%	+$2.91M	0.01%	330
2020 Q4	$192K	Buy	+679	New	+$191K	﹤0.01%	355

Other funds holding WST

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

APG Asset Management Amsterdam, Netherlands $40.7B AUM 39.97% 1-Year Est. Return

PGGM Investments's WST Position: Q2 2025 in Review

PGGM Investments sold out of West Pharmaceutical (WST) in Q2 2025, closing a stake of 4,921 shares — an estimated $1.1M sold.

PGGM Investments first reported a position in WST in Q4 2020 and held it in 17 quarters. The position peaked at $12.4M in Q1 2022. 730 funds tracked by Wall St. Rank hold WST as of Q2 2025.

PGGM Investments reported no remaining West Pharmaceutical position as of Q2 2025 after selling out during the quarter.
PGGM Investments sold 4,921 West Pharmaceutical shares in Q2 2025, an estimated $1.1M.
PGGM Investments first reported a position in West Pharmaceutical in Q4 2020 and held it in 17 quarters.
PGGM Investments's West Pharmaceutical position peaked at $12.4M in Q1 2022.
730 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2025.

Based on PGGM Investments's 13F filing for Q2 2025, filed 18 Jul 2025.